Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > September 27, 2024
Daily News
September 27, 2024
- MHLW Set to Redefine “Vaccines of High Development Priority” in New Plan
September 27, 2024
- Asahi Kasei to Divest Diagnostics Biz to Nagase in July 2025
September 27, 2024
- Fujirebio Files Blood-Based Diagnostic Test for Alzheimer’s in US
September 27, 2024
- Remitch OD Tablets Earns Indonesia Approval: Toray/Meiji Pharma
September 27, 2024
- RaQualia’s Acid Reducer Tegoprazan Approved in Malaysia
September 27, 2024
- Japan Wholesalers Enjoy Growth as COVID Meds Enter Commercial Route
September 27, 2024
- Sawai Joins List of Atomoxetine Recalls after Establishing Test Model
September 27, 2024
- Nobelpharma Takes Nobelzin Patent Fight to IP High Court
September 27, 2024
- Santen Files Glaucoma Drug Sepetaprost in Japan
September 27, 2024
- MHLW to Publish Info Necessary for Driving Biosimilar Switches in FY2025
September 27, 2024
Japan’s pharmaceutical industry has become a global business over the past two decades. Overseas markets now make up nearly three-quarters…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…